The use of mobile phones for the prevention and control of arboviral diseases: a scoping review.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
09 01 2021
Historique:
received: 08 04 2020
accepted: 23 12 2020
entrez: 10 1 2021
pubmed: 11 1 2021
medline: 14 1 2021
Statut: epublish

Résumé

The rapid expansion of dengue, Zika and chikungunya with large scale outbreaks are an increasing public health concern in many countries. Additionally, the recent coronavirus pandemic urged the need to get connected for fast information transfer and exchange. As response, health programmes have -among other interventions- incorporated digital tools such as mobile phones for supporting the control and prevention of infectious diseases. However, little is known about the benefits of mobile phone technology in terms of input, process and outcome dimensions. The purpose of this scoping review is to analyse the evidence of the use of mobile phones as an intervention tool regarding the performance, acceptance, usability, feasibility, cost and effectiveness in dengue, Zika and chikungunya control programmes. We conducted a scoping review of studies and reports by systematically searching: i) electronic databases (PubMed, PLOS ONE, PLOS Neglected Tropical Disease, LILACS, WHOLIS, ScienceDirect and Google scholar), ii) grey literature, using Google web and iii) documents in the list of references of the selected papers. Selected studies were categorized using a pre-determined data extraction form. Finally, a narrative summary of the evidence related to general characteristics of available mobile health tools and outcomes was produced. The systematic literature search identified 1289 records, 32 of which met the inclusion criteria and 4 records from the reference lists. A total of 36 studies were included coming from twenty different countries. Five mobile phone services were identified in this review: mobile applications (n = 18), short message services (n=7), camera phone (n = 6), mobile phone tracking data (n = 4), and simple mobile communication (n = 1). Mobile phones were used for surveillance, prevention, diagnosis, and communication demonstrating good performance, acceptance and usability by users, as well as feasibility of mobile phone under real life conditions and effectiveness in terms of contributing to a reduction of vectors/ disease and improving users-oriented behaviour changes. It can be concluded that there are benefits for using mobile phones in the fight against arboviral diseases as well as other epidemic diseases. Further studies particularly on acceptance, cost and effectiveness at scale are recommended.

Sections du résumé

BACKGROUND
The rapid expansion of dengue, Zika and chikungunya with large scale outbreaks are an increasing public health concern in many countries. Additionally, the recent coronavirus pandemic urged the need to get connected for fast information transfer and exchange. As response, health programmes have -among other interventions- incorporated digital tools such as mobile phones for supporting the control and prevention of infectious diseases. However, little is known about the benefits of mobile phone technology in terms of input, process and outcome dimensions. The purpose of this scoping review is to analyse the evidence of the use of mobile phones as an intervention tool regarding the performance, acceptance, usability, feasibility, cost and effectiveness in dengue, Zika and chikungunya control programmes.
METHODS
We conducted a scoping review of studies and reports by systematically searching: i) electronic databases (PubMed, PLOS ONE, PLOS Neglected Tropical Disease, LILACS, WHOLIS, ScienceDirect and Google scholar), ii) grey literature, using Google web and iii) documents in the list of references of the selected papers. Selected studies were categorized using a pre-determined data extraction form. Finally, a narrative summary of the evidence related to general characteristics of available mobile health tools and outcomes was produced.
RESULTS
The systematic literature search identified 1289 records, 32 of which met the inclusion criteria and 4 records from the reference lists. A total of 36 studies were included coming from twenty different countries. Five mobile phone services were identified in this review: mobile applications (n = 18), short message services (n=7), camera phone (n = 6), mobile phone tracking data (n = 4), and simple mobile communication (n = 1). Mobile phones were used for surveillance, prevention, diagnosis, and communication demonstrating good performance, acceptance and usability by users, as well as feasibility of mobile phone under real life conditions and effectiveness in terms of contributing to a reduction of vectors/ disease and improving users-oriented behaviour changes. It can be concluded that there are benefits for using mobile phones in the fight against arboviral diseases as well as other epidemic diseases. Further studies particularly on acceptance, cost and effectiveness at scale are recommended.

Identifiants

pubmed: 33422034
doi: 10.1186/s12889-020-10126-4
pii: 10.1186/s12889-020-10126-4
pmc: PMC7796697
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

110

Subventions

Organisme : Minciencias
ID : 753
Pays : International
Organisme : Minciencias
ID : 753
Pays : International

Références

PLoS One. 2018 Aug 22;13(8):e0201943
pubmed: 30133492
Sensors (Basel). 2015 May 18;15(5):11431-41
pubmed: 25993517
Comput Ind. 2017 Oct;91:33-44
pubmed: 32287550
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
Ceylon Med J. 2018 Jun 30;63(2):90-91
pubmed: 30064189
Sci Rep. 2018 Aug 20;8(1):12438
pubmed: 30127503
Sci Rep. 2017 Mar 20;7:44778
pubmed: 28317856
Mhealth. 2019 Aug 05;5:23
pubmed: 31559268
Mhealth. 2019 Sep 30;5:45
pubmed: 31620472
J Am Med Inform Assoc. 2018 Jul 1;25(7):841-847
pubmed: 29688391
Cad Saude Publica. 2009;25 Suppl 1:S45-58
pubmed: 19287866
Lancet Glob Health. 2015 Jul;3(7):e356-7
pubmed: 26087979
JMIR Mhealth Uhealth. 2015 Feb 25;3(1):e24
pubmed: 25720457
Stud Health Technol Inform. 2018;250:129-133
pubmed: 29857404
BMC Health Serv Res. 2015 Jul 28;15:288
pubmed: 26216356
JMIR Mhealth Uhealth. 2017 Apr 03;5(4):e41
pubmed: 28373155
Annu Rev Med. 2018 Jan 29;69:395-408
pubmed: 28846489
Ultraschall Med. 2017 Dec;38(6):642-647
pubmed: 28950381
Biomed Microdevices. 2017 Aug 22;19(4):73
pubmed: 28831630
J Clin Diagn Res. 2016 Oct;10(10):JC06-JC10
pubmed: 27891356
Emerg Infect Dis. 2016 Apr;22(4):711-5
pubmed: 26981628
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Biomed Inform. 2012 Feb;45(1):184-98
pubmed: 21925288
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11887-92
pubmed: 26351662
Glob Health Sci Pract. 2019 Mar 29;7(1):128-137
pubmed: 30926741
Glob Health Action. 2014 Oct 27;7:25606
pubmed: 25361730
BMC Health Serv Res. 2018 Apr 10;18(1):265
pubmed: 29631631
BMC Public Health. 2010 Jan 21;10:31
pubmed: 20092624
Public Health. 2019 Mar;168:1-8
pubmed: 30660898
Travel Med Infect Dis. 2013 Jan-Feb;11(1):15-22
pubmed: 23478045
PLoS Med. 2016 Apr 12;13(4):e1002002
pubmed: 27070315
J Biomed Inform. 2016 Apr;60:243-51
pubmed: 26903153
J Health Serv Res Policy. 2005 Jan;10(1):45-53
pubmed: 15667704
BMJ Glob Health. 2018 Jan 4;3(Suppl 1):e000530
pubmed: 29435366
Perspect Public Health. 2014 Jan;134(1):14-5
pubmed: 24395839
PLoS Med. 2013;10(2):e1001382
pubmed: 23424286
BMC Med Res Methodol. 2018 Nov 19;18(1):143
pubmed: 30453902
Parasit Vectors. 2017 Apr 4;10(1):170
pubmed: 28376893
West J Emerg Med. 2016 Nov;17(6):671-679
pubmed: 27833670
J Infect Public Health. 2018 Sep - Oct;11(5):739-741
pubmed: 29606534
PLoS One. 2017 Jun 19;12(6):e0179408
pubmed: 28628629
Emerg Infect Dis. 2013 Apr;19(4):542-50
pubmed: 23628282
Nat Microbiol. 2019 May;4(5):854-863
pubmed: 30833735
Patient Prefer Adherence. 2018 May 14;12:813-822
pubmed: 29785096
Acta Trop. 2016 Oct;162:188-195
pubmed: 27364921
Sci Rep. 2016 Dec 09;6:38223
pubmed: 27934884
FEMS Microbiol Ecol. 2018 Jun 1;94(6):
pubmed: 29617987
BMJ. 2016 Feb 02;352:i657
pubmed: 26839247
PLoS Negl Trop Dis. 2016 Aug 22;10(8):e0004919
pubmed: 27548481
Trop Med Int Health. 2019 Dec;24(12):1411-1426
pubmed: 31626375
P T. 2014 May;39(5):356-64
pubmed: 24883008
Insects. 2015 Jun 11;6(2):576-94
pubmed: 26463204
J Med Internet Res. 2015 Feb 24;17(2):e52
pubmed: 25803266
JMIR Mhealth Uhealth. 2019 Mar 05;7(3):e11420
pubmed: 30457972
Sci Rep. 2019 Nov 15;9(1):16911
pubmed: 31729435
J Health Econ. 2014 May;35:147-61
pubmed: 24681813
JMIR Public Health Surveill. 2017 Oct 02;3(4):e65
pubmed: 28970191
Sci Total Environ. 2009 Mar 15;407(7):2224-33
pubmed: 19157509
Glob Health Sci Pract. 2013 Aug 06;1(2):160-71
pubmed: 25276529
JMIR Public Health Surveill. 2017 May 04;3(2):e26
pubmed: 28473308
Rev Inst Med Trop Sao Paulo. 2017;59:e51
pubmed: 28793020
JAMA Pediatr. 2017 May 1;171(5):461-469
pubmed: 28319239
PLoS One. 2018 Jun 21;13(6):e0199457
pubmed: 29928055
Int J Environ Res Public Health. 2019 Mar 05;16(5):
pubmed: 30841598
BMC Health Serv Res. 2019 Jun 20;19(1):400
pubmed: 31221133
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
JMIR Mhealth Uhealth. 2018 Jul 19;6(7):e161
pubmed: 30026176
Am J Trop Med Hyg. 2011 Jul;85(1):26-33
pubmed: 21734120
BMC Pregnancy Childbirth. 2018 Oct 3;18(1):390
pubmed: 30285669
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Anal Chim Acta. 2019 May 9;1055:140-147
pubmed: 30782365
Elife. 2017 Oct 31;6:
pubmed: 29087296
Am J Prev Med. 2010 Jul;39(1):78-80
pubmed: 20537846
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
BMC Public Health. 2019 Aug 22;19(1):1162
pubmed: 31438908
Methods Inf Med. 2017 Aug 08;56(7):e105-e122
pubmed: 28925418
J Med Entomol. 2013 Jul;50(4):879-89
pubmed: 23926788
N Engl J Med. 2016 Mar 24;374(12):1155-66
pubmed: 27007959
Nat Commun. 2017 Oct 24;8(1):916
pubmed: 29066710
Internet Interv. 2018 Jun 21;13:82-104
pubmed: 30206523
Infect Dis Poverty. 2018 Sep 3;7(1):87
pubmed: 30173662
BMC Health Serv Res. 2019 Oct 15;19(1):699
pubmed: 31615484
Pathog Glob Health. 2012 Dec;106(8):427
pubmed: 23318233
Trends Parasitol. 2018 Sep;34(9):727-729
pubmed: 29793805
PLoS Negl Trop Dis. 2018 Aug 30;12(8):e0006671
pubmed: 30161131
Epidemiol Rev. 2010;32:56-69
pubmed: 20354039
J Glob Health. 2019 Dec;9(2):020425
pubmed: 31893032
Wkly Epidemiol Rec. 2016 Jul 29;91(30):349-64
pubmed: 27476189
Insects. 2016 Dec 17;7(4):
pubmed: 27999305
Health Educ Behav. 2013 Apr;40(2):140-51
pubmed: 22984196
Rev Chilena Infectol. 2015 Jun;32(3):363-4
pubmed: 26230448
J Med Internet Res. 2015 May 14;17(5):e118
pubmed: 25977135
J Med Internet Res. 2017 Nov 09;19(11):e368
pubmed: 29122738
PLoS One. 2017 Oct 2;12(10):e0185551
pubmed: 28968420
Wellcome Open Res. 2017 Sep 22;2:88
pubmed: 29184918

Auteurs

Maria Angelica Carrillo (MA)

Centre for Medicine and Society, Master Programme Global Urban Health, Albert-Ludwigs- University Freiburg, Freiburg im Breisgau, Germany. maria.carrillo@zmg.uni-freiburg.de.

Axel Kroeger (A)

Centre for Medicine and Society, Master Programme Global Urban Health, Albert-Ludwigs- University Freiburg, Freiburg im Breisgau, Germany.

Rocio Cardenas Sanchez (R)

Centre for Medicine and Society, Master Programme Global Urban Health, Albert-Ludwigs- University Freiburg, Freiburg im Breisgau, Germany.

Sonia Diaz Monsalve (S)

Centre for Medicine and Society, Master Programme Global Urban Health, Albert-Ludwigs- University Freiburg, Freiburg im Breisgau, Germany.

Silvia Runge-Ranzinger (S)

Institute of Global Health, Heidelberg University, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH